Pfizer Vaccine Administration

FDA refuses review of mRNA flu vaccine

FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 1d · on MSN

Moderna says FDA refuses to review its application for flu vaccine

· 13h

FDA officials defend decision to not review Moderna’s new flu vaccine

· 1d

F.D.A. Refuses to Review Moderna Flu Vaccine

The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy...

· 22h

Moderna shares fall as FDA declines to review new flu vaccine

· 1d

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

WTVD

Biden administration purchases extra COVID vaccine doses for children, possible booster shots

WASHINGTON -- The Biden administration purchased an additional 200 million doses of Pfizer-BioNTech's COVID-19 vaccine to prepare for potential additional vaccine needs in the US, an administration official familiar with the contract tells CNN. Despite the ...

Honolulu Star-Advertiser

Pfizer defends COVID-19 vaccine effectiveness after Trump criticism

Pfizer said today its COVID-19 vaccine has saved more than 14 million lives worldwide, after President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs. In a post on Truth Social, Trump asserted that he has seen ...

19d

Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research

Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges stronger global competitiveness.

abc7NY

New Pfizer data suggests 3rd COVID vaccine dose 'strongly' boosts protection against delta variant

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday. The data posted online suggest ...